Iron metabolism: Interactions with normal and disordered erythropoiesis

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 5, 2012, Pages

  Ganz, Tomas ^a   Nemeth, Elizabeta ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; FERROPORTIN; HEPCIDIN; IRON;

ARTICLE; BETA THALASSEMIA; ERYTHROID CELL; ERYTHROPOIESIS; HEMOCHROMATOSIS; HUMAN; HYPOXIA; INFLAMMATION; IRON ABSORPTION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON OVERLOAD; IRON TRANSPORT; LIVER CELL; MITOCHONDRION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; ANEMIA; CHRONIC DISEASE; HEMOGLOBINOPATHY; HOMEOSTASIS; IRON METABOLISM DISORDER; METABOLISM; PHYSIOLOGY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ANEMIA; BIOLOGICAL TRANSPORT; CHRONIC DISEASE; ERYTHROID CELLS; ERYTHROPOIESIS; HEMOGLOBINOPATHIES; HOMEOSTASIS; HUMANS; IRON; IRON METABOLISM DISORDERS; MITOCHONDRIA; PROTEIN BIOSYNTHESIS;

EID: 84875321185     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a011668     Document Type: Article

References (71)

1. Adamsky K, Weizer O, Amariglio N, Breda L, Harmelin A, Rivella S, Rachmilewitz E, Rechavi G. 2004. Decreased hepcidin mRNA expression in thalassemic mice. Br J Haematol 124: 123-124.
2. Andriopoulos B Jr., Corradini E, Xia Y, Faasse SA, Chen S, Grgurevic L, KnutsonMD, Pietrangelo A, Vukicevic S, Lin HY, et al. 2009. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 41: 482-487.
3. Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, TaubeDH, Bloom SR, Tam FW, Chapman R, et al. 2010. Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica 95: 505-508.
4. Beguin Y, Stray SM, Cazzola M, Huebers HA, Finch CA. 1988. Ferrokinetic measurement of erythropoiesis. Acta Haematol 79: 121-126.
5. Benyamin B, Ferreira MA, Willemsen G, Gordon S, Middelberg RP, McEvoy BP, Hottenga JJ, Henders AK, Campbell MJ, Wallace L, et al. 2009a. Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat Genet 41: 1173-1175.
6. Benyamin B, McRae AF, Zhu G, Gordon S, Henders AK, Palotie A, Peltonen L, Martin NG, Montgomery GW, Whitfield JB, et al. 2009b. Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. Am J Hum Genet 84: 60-65.
7. Breuer W, Ronson A, Slotki IN, Abramov A, Hershko C, Cabantchik ZI. 2000. The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Blood 95: 2975-2982.
8. Brittenham GM. 2011. Iron-chelating therapy for transfusional iron overload. N Engl J Med 364: 146-156.
9. Bullock GC, Delehanty LL, Talbot AL, Gonias SL, Tong WH, Rouault TA, DewarB, Macdonald JM, Chruma JJ, Goldfarb AN. 2010. Iron control of erythroid development by a novel aconitase-associated regulatory pathway. Blood 116: 97-108.
10. Casanovas G, Swinkels DW, Altamura S, Schwarz K, Laarakkers CM, Gross HJ, Wiesneth M, Heimpel H, Muckenthaler MU. 2011. Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II. J Mol Med 89: 811-816.
11. Casey JL, Hentze MW, Koeller DM, Caughman SW, Rouault TA, Klausner RD, Harford JB. 1988. Iron-responsive elements: Regulatory RNA sequences that control mRNA levels and translation. Science 240: 924-928.
12. Chambers JC, Zhang W, Li Y, Sehmi J, Wass MN, Zabaneh D, Hoggart C, BayeleH, McCarthy MI, Peltonen L, et al. 2009. Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels. Nat Genet 41: 1170-1172.
13. Chen JJ. 2007. Regulation of protein synthesis by the heme-regulated eIF2α kinase: Relevance to anemias. Blood 109: 2693-2699.
14. Chen W, Dailey HA, Paw BH. 2010. Ferrochelatase forms an oligomeric complex with mitoferrin-1 and Abcb10 for erythroid heme biosynthesis. Blood 116: 628-630.
15. Corradini E, Meynard D, Wu Q, Chen S, Ventura P, Pietrangelo A, Babitt JK. 2011. Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice. Hepatology 54: 273-284.
16. Cunningham MJ. 2008. Update on thalassemia: Clinical care and complications. Pediatr Clin North Am 55: 447-460.
17. Du X, She E, Gelbart T, Truksa J, Lee P, Xia Y, Khovananth K, Mudd S, Mann N, Moresco EM, et al. 2008. The serine protease TMPRSS6 is required to sense iron deficiency. Science 320: 1088-1092.
18. Fernandes A, Preza GC, Phung Y, De Domenico I, Kaplan J, Ganz T, Nemeth E. 2009. The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 114: 437-443.
19. Finberg KE, Heeney MM, Campagna DR, Aydinok Y, Pearson HA, Hartman KR, Mayo MM, Samuel SM, Strouse JJ, Markianos K, et al. 2008. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 40: 569-571.
20. Finch C. 1994. Regulators of iron balance in humans. Blood 84: 1697-1702.
21. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. 2008. Immunoassay for human serum hepcidin. Blood 112: 4292-4297.
22. Gardenghi S, Grady RW, Rivella S. 2010a. Anemia, ineffective erythropoiesis, and hepcidin: Interacting factors in abnormal iron metabolism leading to iron overload in beta-thalassemia. Hematol Oncol Clin North Am 24: 1089-1107.
23. Gardenghi S, Ramos P, Marongiu MF, Melchiori L, Breda L, Guy E, Muirhead K, Rao N, Roy CN, Andrews NC, et al. 2010b. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. J Clin Invest 120: 4466-4477.
24. Kearney SL, Nemeth E, Neufeld EJ, Thapa D, Ganz T, Weinstein DA, Cunningham MJ. 2007. Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer 48: 57-63.
25. Kroot JJ, Laarakkers CM, Kemna EH, Biemond BJ, Swinkels DW. 2009. Regulation of serum hepcidin levels in sickle cell disease. Haematologica 94: 885-887.
26. Lee DH, Zhou LJ, Zhou Z, Xie JX, Jung JU, Liu Y, Xi CX, Mei L, Xiong WC. 2010. Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis. Blood 115: 3136-3145.
27. Li H, Rybicki AC, Suzuka SM, von BL, Breuer W, Hall CB, Cabantchik ZI, Bouhassira EE, Fabry ME, Ginzburg YZ. 2010. Transferrin therapy ameliorates disease in β-thalassemic mice. Nat Med 16: 177-182.
28. Liu S, Bhattacharya S, Han A, Suragani RN, Zhao W, Fry RC, Chen JJ. 2008. Haem-regulated eIF2α kinase is necessary for adaptive gene expression in erythroid precursors under the stress of iron deficiency. Br J Haematol 143: 129-137.
29. Maes K, Nemeth E, Roodman GD, Huston A, Esteve F, Freytes C, Callander N, Katodritou E, Tussing-Humphreys L, Rivera S, et al. 2010. In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2. Blood 116: 3635-3644.
30. Mastrogiannaki M, Matak P, Keith B, Simon MC, Vaulont S, Peyssonnaux C. 2009. HIF-2α, but not HIF-1α, promotes iron absorption in mice. J Clin Invest 119: 1159-1166.
31. Mastrogiannaki M, Matak P, Mathieu JR, Delga S, Mayeux P, Vaulont S, Peyssonnaux C. 2011. Hepatic HIF-2 down-regulates hepcidin expression in mice through epo-mediated increase in erythropoiesis. Haematologica doi: 10. 3324/haematol. 2011. 056119.
32. McLaren CE, Barton JC, Gordeuk VR, Wu L, Adams PC, Reboussin DM, Speechley M, Chang H, Acton RT, Harris EL, et al. 2007. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study. Am J Hematol 82: 898-905.
33. Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth MP. 2009. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 41: 478-481.
34. Miller JL. 2012. Iron deficiency anemia: A common and curable disease. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a011866.
35. Nandal A, Ruiz JC, Subramanian P, Ghimire-Rijal S, Sinnamon RA, Stemmler TL, Bruick RK, Philpott CC. 2011. Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2. Cell Metab 14: 647-657.
36. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. 2003. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101: 2461-2463.
37. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. 2004. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113: 1271-1276.
38. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, VaulontS. 2001. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci 98: 8780-8785.
39. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S. 2002. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110: 1037-1044.
40. Ohgami RS, Campagna DR, McDonald A, Fleming MD. 2006. The Steap proteins are metalloreductases. Blood 108: 1388-1394.
41. Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, Nemeth E. 2007. Liver iron concentrations and urinary hepcidin in β-thalassemia. Haematologica 92: 583-588.
42. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. 2006. Suppression of hepcidin during anemia requires erythropoietic activity. Blood 108: 3730-3735.
43. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, DubeMP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, et al. 2004. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36: 77-82.
44. Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, Goldberg YP, Sakellaropoulos N, Ganz T, Nemeth E. 2005. Hepcidin in iron overload disorders. Blood 105: 4103-4105.
45. Paradkar PN, Zumbrennen KB, Paw BH, Ward DM, Kaplan J. 2009. Regulation of mitochondrial iron import through differential turnover of mitoferrin 1 and mitoferrin 2. Mol Cell Biol 29: 1007-1016.
46. Pietrangelo A, Dierssen U, Valli L, Garuti C, Rump A, Corradini E, Ernst M, KleinC, Trautwein C. 2007. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 132: 294-300.
47. Pietrangelo A, Caleffi A, Corradini E. 2011. Non-HFE hepatic iron overload. Semin Liver Dis 31: 302-318.
48. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O. 2001. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276: 7811-7819.
49. Porter JB. 2009. Pathophysiology of transfusional iron overload: Contrasting patterns in thalassemia major and sickle cell disease. Hemoglobin 33: S37-S45.
50. Poss KD, Tonegawa S. 1997. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci 94: 10919-10924.
51. Ramos E, Kautz L, Rodriguez R, Hansen M, Gabayan V, Ginzburg Y, Roth MP, Nemeth E, Ganz T. 2011. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology 53: 1333-1341.
52. Salahudeen AA, Thompson JW, Ruiz JC, Ma HW, Kinch LN, Li Q, Grishin NV, Bruick NK. 2009. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science 326: 722-726.
53. Sanchez M, Galy B, Schwanhaeusser B, Blake J, Bahr-Ivacevic T, Benes V, Selbach M, Muckenthaler MU, Hentze MW. 2011. Iron regulatory protein-1 and-2: Transcriptome-wide definition of binding mRNAs and shaping of the cellular proteome by iron regulatory proteins. Blood 118: e168-e179.
54. Sham RL, Phatak PD, Nemeth E, Ganz T. 2009. Hereditary hemochromatosis due to resistance to hepcidin: High hepcidin concentrations in a family with C326S ferroportin mutation. Blood 114: 493-494.
55. Sheftel AD, Zhang AS, Brown C, Shirihai OS, Ponka P. 2007. Direct interorganellar transfer of iron from endosome to mitochondrion. Blood 110: 125-132.
56. Shi H, Bencze KZ, Stemmler TL, Philpott CC. 2008. A cytosolic iron chaperone that delivers iron to ferritin. Science 320: 1207-1210.
57. Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C. 2008. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 8: 502511.
58. Soe-Lin S, Apte SS, Andriopoulos B Jr., Andrews MC, Schranzhofer M, KahawitaT, Garcia-Santos D, Ponka P. 2009. Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo. Proc Natl Acad Sci 106: 5960-5965.
59. Talbot AL, Bullock GC, Delehanty LL, Sattler M, Zhao ZJ, Goldfarb AN. 2011. Aconitase regulation of erythropoiesis correlates with a novel licensing function in erythropoietin-induced ERK signaling. PLoS ONE 6: e23850.
60. Tanaka T, Roy CN, Yao W, Matteini A, Semba RD, Arking D, Walston JD, FriedLP, Singleton A, Guralnik J, et al. 2010. A genome-wide association analysis of serum iron concentrations. Blood 115: 94-96.
61. Tanno T, Bhanu NV, Oneal PA, Goh SH, Staker P, Lee YT, Moroney JW, Reed CH, Luban NL, Wang RH, et al. 2007. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 13: 1096-1101.
62. Tanno T, Porayette P, Sripichai O, Noh SJ, Byrnes C, Bhupatiraju A, Lee YT, Goodnough JB, Harandi O, Ganz T, et al. 2009. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 114: 181-186.
63. Telfer P. 2009. Update on survival in thalassemia major. Hemoglobin 33: S76-S80.
64. Troadec MB, Warner D, Wallace J, Thomas K, Spangrude GJ, Phillips J, Khalimonchuk O, Paw BH, Ward DM, Kaplan J. 2011. Targeted deletion of the mouse Mitoferrin1 gene: From anemia to protoporphyria. Blood 117: 5494-5502.
65. Vashisht AA, Zumbrennen KB, Huang X, Powers DN, Durazo A, Sun D, Bhaskaran N, Persson A, Uhlen M, Sangfelt O, et al. 2009. Control of iron homeostasis by an iron-regulated ubiquitin ligase. Science 326: 718-721.
66. Verga Falzacappa MV, Vujic SM, Kessler R, Stolte J, Hentze MW, MuckenthalerMU. 2007. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109: 353-358.
67. Verga Falzacappa MV, Casanovas G, Hentze MW, Muckenthaler MU. 2008. A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells. J Mol Med 86: 531-540.
68. Vokurka M, Krijt J, Sulc K, Necas E. 2006. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res 55: 667-674.
69. Wallace DF, Summerville L, Crampton EM, Frazer DM, Anderson GJ, Subramaniam VN. 2009. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology 50: 1992-2000.
70. Wrighting DM, Andrews NC. 2006. Interleukin-6 induces hepcidin expression through STAT3. Blood 108: 3204-3209.
71. Zhang DL, Hughes RM, Ollivierre-Wilson H, Ghosh MC, Rouault TA. 2009. A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab 9: 461-473.